Pharmaceutical R & D GAP:

Drugs for Neglected Diseases Initiative (DNDI)

www.neglecteddiseases.org

• Needs driven, public sector not for profit research and development capacity building initiative

• Drugs for neglected diseases

• Equitable access to new drugs at cost

• Private sector collaboration on a contractual or pro bono basis

• Coordination with TDR

• Private funding 30% - public sector 70%

  
  

ASTMH has signed on to offer expertise - 2002

Previous slide

Next slide

Back to first slide

View graphic version